Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 EP303 | DOI: 10.1530/endoabs.70.EP303

1İstanbul Medipol University, Endocrinology and Metabolism, İstanbul, Turkey; 2İstanbul Medipol University, Internal Medicine, İstanbul, Turkey; 3İstanbul Medipol University, Radiology, İstanbul, Turkey


Both pituitary and adrenal gland metastases of lung cancer are very rare. A 79-year-old male patient with diabetes mellitus and hypertension was admitted to our hospital because of a mass in the lungs of the thorax CT. TSH: <0.005 UIU/ml (0.27–4.2), free T4: 0.794 ng/dl (0.93–1.7). Other pituitary hormones were also examined: FSH: 0.708 mIU/ml (1.5–12.4), LH: <0.1 mIU/ml (1.7–8.6), prolactin: 12.7 ng/ml (4.04–15.2), total testosterone: <0.025 ng/ml (1.93–7.4), cortisol: 1 µg/dl (6.02–18.4) was found to be. Pituitary MRI showed an infiltrative mass in the hypothalamus and stalk. PET/CT showed a malignant mass in the right hilar area, metastatic lymph nodes in the mediastinum, and diffuse metastasis in the left adrenal and bones. Pathological diagnosis in trucut needle biopsy from the right supraclavicular lymph node: Reported as metastasis of non-small cell lung carcinoma. The pituitary and adrenal masses were accepted as lung cancer metastasis. The patient was started on prednisolone 5mg, levothyroxine 25 µg/day. Diabetes insipitus was not considered due to lack of increase in urine volume and normal urine density and serum sodium levels. Patient oncology and radiation oncology were consulted and radiotherapy and chemotherapy were planned. Although fatigue is a common symptom in lung cancer cases, it should be kept in mind that metastasis to the pituitary and/or adrenal gland may occur in these patients

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts